Navigation Links
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI® Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis
Date:11/11/2010

0;For additional information on psoriatic arthritis, visit the National Psoriasis Foundation.

About SIMPONI

SIMPONI is a human monoclonal antibody that targets and neutralizes excess TNF-alpha, a protein that when overproduced in the body due to chronic inflammatory diseases can cause inflammation and damage to bones, cartilage and tissue. A once-monthly subcutaneous anti-TNF-alpha therapy with marketing authorizations in the Unites States, Europe and Canada, SIMPONI is approved for the treatment of moderately to severely active RA in combination with methotrexate, active PsA and active AS.  SIMPONI is available either through the SIMPONI SmartJect® autoinjector or a prefilled syringe.  For more information about SIMPONI, visit www.SIMPONI.com.  

Centocor Ortho Biotech Inc. discovered and developed SIMPONI and has exclusive marketing rights to the product in the United States.

Important Safety Information

SIMPONI® (golimumab) is a prescription medicine. SIMPONI® can lower your ability to fight infections. There are reports of serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor will test you for TB before starting SIMPONI® and will monitor you for signs of TB during treatment. Tell your doctor if you have been in close contact with people with TB. Tell your doctor if you have been in a region (such as the Ohio and Mississippi River Valleys and the Southwest) where certain fungal infections like histoplasmosis or coccidioidomycosis are common.

You should not start SIMPONI® if you have any kind of infection. Tell your doctor if you are prone to or have a history of infections or have
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotechs New Psoriasis Agent Stelara (ustekinumab) is High
2. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
3. Chesley Files Class Action Against DePuy Orthopaedics
4. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
5. Hanger Orthopedic Group, Inc. Announces Early Tender Results of Offer to Purchase Outstanding 10-1/4% Senior Notes Due 2014
6. Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStems Licensed Adult Stem Cell Treatments for Orthopedic Applications in China
7. New Orthopedic Market Research Data Covering Multiple Geographies Released by Millennium Research Group
8. Merlot OrthopediX Enters into Exclusive Global Agreement with Alphatec Spine to Develop and Market Merlots Bone Anchorage Technology for the Treatment of Spine Disorders
9. Hanger Orthopedic Group, Inc. Announces Pricing of $200 Million of Senior Notes
10. Hanger Orthopedic Group Signs Definitive Merger Agreement To Acquire Accelerated Care Plus
11. Hanger Orthopedic Group Announces Preliminary Third Quarter Revenue and Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 ... stage. Growing ageing population and rise in the incidence ... of chronic wounds and in affordability of better quality ... Chinese wound care market. Universal coverage of public health ... products would further stimulate demand. Based on the findings ...
(Date:9/30/2014)... 30, 2014  Based on its recent analysis ... Sullivan recognizes Ventana Medical Systems, Inc. (Ventana), a ... North American Frost & Sullivan Award for Technology ... with a focus on innovation and improving patient ... tissue-based cancer diagnostic solutions for patients worldwide. ...
(Date:9/30/2014)... Passport Health, one of the largest immunizers ... FluFree.com, a website designed to promote, educate about, and ... years, Passport Health has provided its clients with protection ... FluFree.com is designed to address the growing gap between ... who actually chose to get vaccinated. "We ...
Breaking Medicine Technology:China Wound Care Market 2China Wound Care Market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 2Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 3
... WIRE)--May 10, 2007 - An evaluation of the,safety ... the,treatment of vaginal atrophy, a frequent complaint of,postmenopausal ... American,Menopause Society (NAMS). Entitled "The role of local ... women:,2007 position statement of The North American Menopause ...
... Technology Demonstrates Novel,Anti-Inflammatory Properties, New Surfaxin ... Academic,Societies Annual Meeting , WARRINGTON, Pa., ... Discovery,Laboratories, Inc. (Nasdaq:DSCO) announced that new ... novel KL-4 surfactant,(lucinactant) replacement technology were ...
Cached Medicine Technology:New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 2New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 3Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 2Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 3Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 4Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 5Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 6
(Date:9/30/2014)... NJ (PRWEB) September 30, 2014 ... and wellness, is opening another new medical specialty practice ... IMA Cardiology will be located within the ... Ziad Abbud and Dr. Isaac Tawfik of American Heart ... N.J. The new practice will offer Integrated Medicine Alliance ...
(Date:9/30/2014)... research team has been awarded a three-year $1.7 ... (NIH) to develop new imaging technologies and data ... how large networks of neurons in the brain ... help researchers identify the precise interactions between millions ... and speaking, and alterations in these interactions that ...
(Date:9/30/2014)... 30, 2014 Elevate , the latest ... better in and out of the gym by providing natural ... the attention of Shane Michaels, prompting an investigative review. ... the reason most people simply just don’t have the ability ... focused at work, getting the motivation to finish a project, ...
(Date:9/30/2014)... 2014 Hospice & Palliative Care ... Celebration” gala, honoring three outstanding individuals for their ... to provide extraordinary and dignified comfort, care and ... or life-limiting illness. , The event was held ... and recognized William (Bill) J. McGuinness, Director of ...
(Date:9/30/2014)... Dr. Karl R.O.S. Johnson, DC, has developed ... care that is dramatically improving the health and lives ... & Nutrition—applies a proprietary, multi-dimensional approach that goes beyond ... of inflammation, neurology of the joint and neurology of ... brain to the spine, to the legs, knees and ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3
... neuropathy than blood glucose levels, study suggests , , THURSDAY, ... levels of triglyceride fats are at increased risk of ... or damage of nerves that results in numbness, tingling ... researchers say. , A study by U.S. researchers ...
... 2009 In an effort that will contribute ... and the surrounding region, the country,s National Center ... Calidad (CNCC)has attained internationally recognized ISO/IEC 17025:2005 accreditation ... being celebrated today in Lima by the CNCC ...
... NEW YORK, May 21 The Journal of Visual ... on blindness and visual impairment from AFB Press, is now ... access and $65 for a combined print and online subscription."For ... of the field,s literature by keeping professionals and students up-to-date ...
... HealthEast Care System hospitals have agreed to pay ... that the health care facilities submitted false claims ... three hospitals are located in the Minneapolis-St. Paul, ... Paul-based hospitals overcharged Medicare from 2002 to 2007 ...
... According to a new Mayo Clinic study, a history ... challenges facing depressed inpatients. Included are an increase in ... higher incidence rate of personality disorder. Additionally, these victims ... an increase in psychiatric hospitalizations for psychiatric issues. The ...
... May 21 Mayo Clinic researchers have found that ... such as diabetes, depression, asthma or coronary artery disease. ... care claim costs. Specialty care costs (the costs of ... higher for bipolar patients. Results of this review are ...
Cached Medicine News:Health News:High Blood Fats Tied to Diabetic Nerve Loss 2Health News:Medication quality in Peru and region strengthened with official laboratory's accreditation 2Health News:New Reduced Subscription Rate to Leading International Journal on Blindness and Low Vision 2Health News:Minnesota Hospitals to Pay U.S. $2.28 Million to Settle False Claims Act Allegations 2Health News:Specialty Care Costs for Patients With Bipolar Disorder Are Higher Than Diabetes and Other Chronic Diseases 2
Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....
Straight shafts with two point fixation. Tips separated by 3 mm, each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with dull finish....
Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....
Straight shafts with 25 degree angled 1.5 mm tips. 4 mm platform with 0.12 mm, 1 x 2 teeth. Wide serrated handle with polished finish....
Medicine Products: